Calorub Parche

Quick links to important sections

Calorub Parche

Treatment option:

Medically reviewed

Marina Burgos

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Calorub Parche

What Kind of Medicine is Calorub Parche?

Calorub Parche is an Over-The-Counter (OTC) pharmaceutical product categorized primarily as a Topical Analgesic, delivered in an adhesive patch dosage form for exclusive external use. This delivery method utilizes a Transdermal System to provide a sustained, topical release of active ingredients. The patch format distinguishes it from gels or creams by localizing the effect and providing prolonged action without requiring manual re-application. This delivery system is designed for adults seeking continuous relief from temporary localized discomfort.

What is the Composition and Pharmacological Class?

The essential active ingredient in Calorub Parche is Methyl Salicylate, a salicylate derivative that is often included in a combination product with supplementary agents such as Menthol or Camphor. Methyl Salicylate contributes the primary anti-discomfort action, while the other components enhance the sensory effect on the skin. The medicine's core classification is that of a Counter-irritant and Rubefacient. The patch functions by creating a noticeable, non-painful stimulation on the skin surface, which assists in alleviating the perception of deeper muscular or joint discomfort.

What is the General Purpose of the Analgesic Patch?

The general purpose of the analgesic patch is to offer temporary, localized comfort for common muscular and joint aches and stiffness. A typical use scenario involves applying the patch to a stiff lower back or a sore shoulder after physical exertion. Its function relies on the principles of counter-irritation, where the sensory input from the patch—often experienced as warmth—distracts the nervous system from the underlying tension. The localized delivery inherent to the patch form enables continuous, focused relief over a defined period, focusing the action precisely where it is needed to improve comfort and reduce the feeling of stiffness.

What side effects are possible with Calorub Parche?

Possible Side Effects and Safety Information

This section describes the officially documented adverse reactions and safety characteristics for Calorub Parche (a topical salicylate patch), based on government regulatory classifications.

Adverse Reactions and Frequency

The safety profile is characterized by effects classified primarily as Skin and Subcutaneous Tissue Disorders. Common adverse reactions typically documented include localized skin irritation, erythema (redness), pruritus (itching), and a localized burning sensation at the application site. These effects are generally transient and linked to the counter-irritant nature of the active components.

Rare but serious adverse reactions are documented, including generalized hypersensitivity or anaphylactic reactions. There is also a rare, documented risk of severe burns (second- or third-degree) at the application site, particularly if external heat sources are used concurrently. Furthermore, systemic absorption, especially with excessive application, introduces a rare risk of systemic salicylate toxicity (salicylism).

Safety Considerations and Restrictions

Official labeling defines specific constraints to manage risk. The patch must not be applied to damaged, broken, or irritated skin to prevent excessive systemic absorption of methyl salicylate. The use of external heat sources, such as heating pads, over the patch is strictly forbidden due to the risk of severe burns.

The regulatory profile includes population-specific safety constraints. The product is contraindicated in individuals with a known allergy to aspirin or other Nonsteroidal Anti-inflammatory Drugs (NSAIDs). Use is generally not recommended or restricted in children under 12 or 18 years of age, and use is contraindicated after 20 weeks gestation due to potential risks to the fetus. The risk of systemic side effects, such as gastrointestinal bleeding, is documented as potentially greater with long-term exposure.

Overdose and Emergency Response

Overdose from the active ingredient, Methyl Salicylate, may lead to Systemic Salicylate Toxicity (Salicylism) following accidental ingestion or excessive dermal use. Regulatory documents define the initial manifestations to include auditory signs such as tinnitus (ringing in the ears), alongside gastrointestinal effects like nausea and vomiting, and respiratory changes like tachypnea (abnormally rapid breathing). Other documented signs of toxicity are headache, dizziness, and diaphoresis (excessive sweating).

Severe or life-threatening systemic outcomes are recognized and require urgent care. These documented outcomes include CNS effects such as seizures and coma, as well as critical metabolic derangements like severe metabolic acidosis and hyperthermia. Complications may also involve pulmonary edema and cardiovascular collapse. The pediatric population is noted in regulatory documents as being at higher risk for severe systemic toxicity from small ingestions.

Immediate medical attention is required for any suspected overdose or accidental ingestion, or upon the appearance of documented systemic symptoms such as persistent vomiting, confusion, or a change in level of consciousness. The official management profile is symptomatic and supportive, and regulatory labeling states that no specific antidote is known for salicylate poisoning. Management procedures may include hospital monitoring of serum salicylate levels and acid-base status, with procedures such as hemodialysis reserved for severe cases.

Therapeutic Uses of Calorub Parche

What Calorub Parche Treats: Main Uses and Benefits

Calorub Parche is applied across domains where additional symptomatic support is needed, primarily focusing on symptoms related to physical discomfort. It is considered relevant in situations involving symptom clusters that create noticeable functional strain and interfere with daily comfort. This therapeutic category is commonly used to help with minor aches and pains of muscles and joints associated with conditions such as strains, sprains, and simple backache.


Key Therapeutic Domains

The Parche is generally applied in scenarios where additional management of discomfort is appropriate for conditions presenting with systemic or localized discomfort. This assists patients during episodes of heightened discomfort, which may contribute to easing the overall symptom load related to muscle and joint tension.

The clinical scenario involves short-term symptomatic assistance for acute or disruptive episodes. This product may offer supportive relief when symptoms become momentarily overwhelming, helping patients cope more steadily with difficult episodes where discomfort may intensify temporarily.

“It provides supportive relief when symptoms interfere with routine activities.”


Quick Fact Summary

  • Quick Fact: Relief for Localized Discomfort Calorub Parche is commonly used across conditions presenting with acute episodes and offers symptomatic relief to help ease the overall symptom burden.

Regulatory References

  1. Health Canada Natural Health Product Directorate (NHPID) entry on Counterirritants

Eligibility and Restrictions for Use

Calorub Parche is authorized for use in adults 18 years of age and older. Use is strictly not recommended in children and teenagers younger than 18 without a healthcare professional's guidance. The patch is contraindicated for children under 18 with flu, chickenpox, or recent vaccination due to Reye's Syndrome risk.

The medicine is contraindicated for several populations as defined by regulatory documents:

  • Individuals with a known allergy or hypersensitivity to salicylates, aspirin, NSAIDs, menthol, or camphor.
  • Pregnant individuals from 20 weeks gestation until delivery.
  • Patients with Severe Renal Impairment.
  • Application on any broken, irritated, or compromised skin.

Conditional use is required for other populations. Patients with pre-existing conditions like asthma, high blood pressure, heart disease, or kidney disease must consult a professional before use. Caution is also advised for patients age 60 or older and those who are breastfeeding or in the early stages of pregnancy (up to 19 weeks gestation). The patch must not be used with heating pads or immediately before or after strenuous activity.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Official regulatory information for topical products like Calorub Parche, which is formulated for local action, generally indicates a low risk for systemic drug-drug interactions with oral or injectable medications. This is due to minimal systemic absorption of the active ingredients.

Pharmacokinetic and Systemic Interactions

No specific, detailed pharmacokinetic interaction data—such as effects on cytochrome P450 (CYP) enzymes, drug transporters (P-gp, OATP), or resulting changes in AUC/Cmax of co-administered systemic drugs—are typically provided in widely available regulatory documents for this product.

Consequence: The official labeling does not specify restrictions or timing requirements for most oral medications, including prescription drugs, based on these mechanisms.

Pharmacodynamic and Topical Interactions

Interaction Type Regulatory Status/Constraint
Topical Overlap It is generally recommended not to apply the patch to the same skin area simultaneously with other topical products to avoid additive local effects (e.g., irritation or redness).
Contraindicated Combinations No absolute contraindicated combinations with systemic medications are formally specified in the available regulatory documents.

Food, Alcohol, and Herbal Products

Official regulatory documents contain no explicit warnings regarding interactions between the active ingredients of the patch and the consumption of food, alcohol, or specific herbal or dietary supplements. The localized route of administration minimizes the potential for such conflicts.

Mechanism of Action

How Calorub Parche Works


Modulating Nociceptor-Mediated Signaling

The drug engages signaling domains involving receptor- or enzyme-mediated activity, influencing primary afferent neurons. This interaction initiates a sequence of events that results in a measurable change in baseline neuronal activity and the transmission of afferent signals.


Regulating Pathway Activity via Transmitters

The patch modulates specific pathways associated with elevated physiological responses through its influence on localized systems where specific transmitters or mediators dominate. It modifies the threshold for mediator release and subsequent activity, driving an alteration toward a lower activation state within the targeted sensory pathways, thereby influencing overall sensory transduction.


Influencing Local Vasoregulation Mechanisms

Calorub Parche engages mechanisms that regulate localized physiological processes, including microcirculatory dynamics. This mechanism influences local pathways to produce vasoregulatory changes at the application site, resulting in a shift in local physiological output associated with thermal and circulatory responses.

Dosage and Administration Information

How to Use Calorub Parche

This section describes the administration principles for the topical analgesic patch for proper use.


Administration Scope and Dosing

Feature General Instruction
Route of administration Topical (External Use Only). The medicine is absorbed through the skin for localized effect.
Dosing schedule Apply one (1) patch to the single affected area. Use is limited to a maximum of three (3) to four (4) patches daily (in a 24-hour period), adhering to the specific product labeling.
Frequency pattern Intermittent, as-needed (PRN) use, with a patch typically remaining in place for up to 8 to 12 hours before replacement.
Duration constraint Use must be limited to short-term periods, generally not exceeding 7 continuous days, for temporary relief.

Procedural and Population Rules

  • Preparation: The patch must be applied only to clean, dry, intact skin that is free of irritation, wounds, or rashes.
  • Application Rules: The patch must not be cut or divided unless explicitly instructed by the manufacturer. External heat (e.g., heating pads) must not be applied over the patch site, as this can increase absorption.
  • Age-Group Use: The product is generally approved for use in adults and children 12 years of age and older. Use in children younger than 12 years requires consultation with a healthcare professional.

These instructions define a standardized topical use protocol designed to optimize localized effect while restricting total exposure. The clear limits on the dose, frequency, and duration ensure the medicine is employed solely for acute, temporary symptomatic use.

Recent Clinical Evidence

Research Evidence / Overview of Studies


Evaluating the Drug's Effect on Pain

Research has investigated the drug's use in subjects with acute and chronic pain. Studies were conducted to evaluate the time course and magnitude of differences in pain scores during the research period. The reviewed trials primarily focused on quantifying changes in standard pain assessment tools and collecting participant-reported outcomes.

The studied dose range typically began at the lowest therapeutic level. Dosage adjustments in the reviewed trials were often guided by pre-defined protocols.


Combination Therapy Studies

Studies have evaluated whether the combination of the drug with standard Nonsteroidal Anti-inflammatory Drugs (NSAIDs) could potentially influence measures of overall pain relief. The research examined variables such as changes in the required dose of the NSAID and the duration of perceived pain relief.

Adverse events and side effects were systematically measured and recorded across the studies. Participants with pre-existing liver conditions were generally excluded or closely monitored in research protocols.


Comparative Studies

Research has compared the drug's effects to both placebo and other established pain-relieving agents, as part of pain treatment protocols. These studies focused on differences in pain reduction scores, the time to onset of perceived change, and the frequency of reported adverse events. The results of these comparative studies were often based on randomized, controlled trial designs.


Use in Neuropathic Pain

Research has investigated the drug's effects in managing nerve pain. This research stream focuses on the drug's effects in comparison to traditional pain treatments. Specific research outcomes focused on validated neuropathic pain scores.

Key Studies & References

  1. Neuropathic pain in adults: pharmacological management in non-specialist settings (NICE Guideline)

Frequently Asked Questions (FAQ)

Common questions about Calorub Parche (FAQ)

Q: How quickly does a Calorub Parche typically start working?

A: Research has investigated the effects of the patch on pain relief. Studies examine the time course and magnitude of the effects, with one focus area being the time to onset of perceived change in pain relief reported by participants.


Q: How long does the effect of one Calorub Parche usually last?

A: According to official product information, a single patch typically remains in place for an extended period, generally for up to 8 to 12 hours, before a replacement may be considered. The patch is designed as a transdermal system to provide a sustained, localized release of the active ingredients throughout this period.


Q: Is Calorub Parche safe to use on sensitive skin?

A: Regulatory documents describe application principles, including the use of the patch only on clean, dry, and intact skin, avoiding broken or irritated areas. Officially documented side effects commonly include localized skin irritation, redness (erythema), and a burning sensation, which are linked to the counter-irritant nature of the active components.


Q: Can Calorub Parche be used for everyday muscle soreness?

A: The general purpose of the patch, as defined in official documents, is the temporary, localized relief of common muscular and joint aches. Official guidelines limit the use to short-term periods, generally not exceeding seven continuous days, for acute symptomatic relief.


Q: What is the difference between Calorub Parche and a topical cream with similar ingredients?

A: Calorub Parche is defined as a Transdermal System (patch), which provides a sustained, topical release and focused action over a defined period. This distinguishes the dosage form from creams or gels by localizing the effect and providing prolonged action without requiring manual re-application.


Q: Does using Calorub Parche cause a warming or cooling sensation?

A: The active ingredients are classified as counter-irritants, which are known to influence local sensory perception. Menthol is typically associated with a cooling sensation, and Methyl Salicylate and Camphor often contribute to a warming or stimulating sensation at the application site, driving a localized thermal response.


Q: Are there any specific activities to avoid while wearing Calorub Parche?

A: Official guidance strictly forbids the application of external heat sources, such as heating pads, over the patch site. This caution is defined because external heat may increase the absorption of the medicine and the risk of local adverse reactions, including burns. Caution is also advised regarding application immediately before or after strenuous activity.


Q: Does the active ingredient in Calorub Parche enter the bloodstream?

A: The localized route of administration results in minimal systemic absorption of the active ingredients. Official information does caution about the rare, documented risk of systemic salicylate toxicity (salicylism), which may occur with excessive or inappropriate use.


Q: Can Calorub Parche be used at the same time as other oral pain medications?

A: Official regulatory information indicates a generally low risk for systemic drug-drug interactions with oral or injectable medications due to minimal systemic absorption. No specific restrictions are specified in official labeling regarding timing or concurrent use with oral medications.


Q: Are there known interactions between Calorub Parche and blood thinners?

A: Because the active ingredient is a salicylate derivative, regulatory warnings for salicylate products often advise caution regarding concurrent use with blood thinners (anticoagulants). Official safety guidance advises caution with excessive usage due to the potential for increased systemic effects.


Q: Is Calorub Parche appropriate for use by elderly people?

A: Official product information advises caution for patients age 60 or older and designates this as a conditional use population. Specific restrictions beyond this conditional use are defined in official documents.


Q: Are there known drug interactions with common anti-depressants?

A: Official regulatory documents contain no explicit warnings regarding specific interactions with common systemic medications like anti-depressants. This aligns with the understanding that the localized route of administration leads to minimal systemic absorption, thereby minimizing the potential for drug-drug interactions.


Q: Why might a doctor suggest Calorub Parche instead of pills?

A: The patch provides a localized route of administration, a method associated with a lower total systemic exposure to the medicine compared to oral forms. This allows for the active ingredients to be focused topically and released in a sustained manner.


Q: Can the patch be applied to joints like the knee or elbow?

A: The patch is authorized for the temporary, localized relief of minor aches in both muscles and joints. The application area is generally defined as the single affected area, which would include major joints such as the knee or elbow.


Q: What is the role of any inactive ingredients in the patch?

A: Inactive ingredients are required to be listed in the official product labeling. Their primary role is structural, providing the necessary components for the patch itself, such as the adhesive and backing material, and supporting the stability and effective delivery of the active medicinal components.


Q: Are there any dietary considerations mentioned in connection with using Calorub Parche?

A: Official regulatory documents contain no explicit warnings regarding interactions between the active ingredients of the patch and the consumption of food, alcohol, or specific herbal or dietary supplements. The localized administration route minimizes the potential for such conflicts.


Q: What are the most commonly reported reasons for discontinuing use of Calorub Parche?

A: The most common adverse reactions reported in official documents are linked to the counter-irritant nature of the patch, including localized skin irritation, redness (erythema), and itching (pruritus) at the application site. These local reactions are typically the reasons cited when discussing the tolerability of the patch.


Q: Does exposure to heat, like a sauna, affect the patch's performance?

A: Official warnings strictly forbid applying external heat sources (like heating pads) over the patch site because this may increase absorption and the risk of burns. This general caution is related to external heat sources, as increased skin temperature could potentially affect the local absorption rate and the intensity of the patch's effect.

How should Calorub Parche be stored and disposed of?

Storage Conditions and Stability

Calorub Parche must be stored at controlled room temperature, specifically between 20°C and 25°C (68°F and 77°F). It is required to protect the product from excessive moisture, direct sunlight, and freezing. The patches should remain in their original pouch until ready for application, and the pouch must be resealed immediately after opening.

Packaging and Shelf-Life

To ensure stability, any patch taken from a pouch that has been open for 14 or more days must be discarded. The product, both new and used, must be kept out of the sight and reach of children and pets. This is a mandatory safety requirement.

Disposal Instructions

For disposal, the used patch must be folded with the sticky ends together. Unused or expired medication should be taken to a medication take-back program. Do not flush the patches down the toilet or pour them down a drain unless explicitly told to do so by a healthcare provider or specific local regulation.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Calorub Parche found in:

A-Z Index: